UW Bioengineering
Fast Facts
News and Events
Engineering solutions for heart health
At the UW Institute for Stem Cell and Regenerative Medicine (ISCRM), researchers are unraveling the mysteries of the human heart through innovative engineering
Events
Kelly Stevens co-leads new NIH-funded center to reduce disparities in biomaterials research
The National Institutes of Health is supporting a new center to advance biomaterials research and connect researchers with a grant of $10.5 million.
Amy Orsborn receives prestigious NSF CAREER award
Amy Orsborn, has received a prestigious NSF CAREER award to support her research in sensorimotor neural interfaces.
Exceptional department review highlights strengths of UW Bioengineering
The University of Washington Graduate School recently conducted a thorough review of the Department of Bioengineering.
News & Events
Featured Publications
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted rat hearts
Ying Zheng and colleagues demonstrate that engineered perfusable microvessel grafts enhance vascular remodeling and accelerate coronary perfusion, potentially supporting cardiac tissues after implantation.
Engineering a multicellular vascular niche to model hematopoietic cell trafficking
Assistant Professor Ying Zheng and colleagues developed an engineered human vascular marrow niche to examine the three-dimensional cell interactions that direct hematopoietic cell trafficking. The platform provides a tool to advance study of the interactions between endothelial cells, marrow-derived fibroblasts and hematopoeitic cells that comprise the marrow vascular niche, and has potential for use in testing therapeutics and personalized medicine.
Human Organ-Specific Endothelial Cell Heterogeneity
BioE faculty Charles Murry, Kelly Stevens and Ying Zheng, and interdisciplinary colleagues from across UW, investigated the properties of endothelial cells (ECs), isolated from four human major organs—the heart, lung, liver, and kidneys—in individual fetal tissues at three months' gestation, at gene expression, and at cellular function levels. Their findings showed the link between human EC heterogeneity and organ development and can be exploited therapeutically to contribute in organ regeneration, disease modeling, as well as guiding differentiation of tissue-specific ECs from human pluripotent stem cells.
